NSE:STAR #NSE:STAR reached to key support level, stuck between 308-326, breaking these levels may expect good momentum. All possible levels marked on chart, Observe and levels and share your experience. Hi Friends, For the past few days i was not able to share any charts due to technical error from TV. Many of you reached to me with the medium available in...
STAR HEALTH under dip and consolidation in day and weekly. Monthly V shape recovery is possible. Target 489
STRIDES PHARMA SCIENCE under dip. Towards primary support trend. If it reaches to primary trend and bounds back to 419 and sustains, it will reach 499
Bearish impulse move may happen concentrate if price sustain below 400
STAR - Strides Pharma Short & Long Term Stock.. 700 - 1000
STRIDES PHARMA breached out major support zone if we get a puuback a good short opprtunity can be seen in star
The stock is in a high downtrend and would be weaker if starts trading below 470 for the marked targets on the chart with white lines until we see a close above 510. To motivate me, Please like the idea If you agree with the analysis. Happy Trading! InvestPro India Team
Star( strides pharma) By above 465 Target 493,499,516 Below 458 Target 448,421
Bearish impulse move may happen concentrate if price sustain below 486
Refer the charts to see the inverse H&S formed on charts of Strides Pharms, seems like stock is bottoming out. Wait for the breakout of 530 levels with good volumes. SL : 490 Targets: 580 and 600
STAR : Intraday View Can break immediate resistance Long above 522.5 with SL 519
CMP: 819.5, T: 920, SL: 742 Study: 1. Bounce back from support 2. Trend line breakout with huge volume
STAR : Beautiful Round bottom Looks determined to shoot up Long above 515 with SL 505
Star analysis was shared 29 Aug when CMP was 603 . Told that it is going to hit 530 level. And that is the support area for the stock. STAR Buy - 525-530 Sl- 510 Target - 670 740
Buy Star CMP 590 Stoploss 565 Target 630 Downward Trendline Breakout
short this ... an hagging man is seen in the 15 min chart of strides pharma